Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.

Slides:



Advertisements
Similar presentations
Microbiology in the K-16 Classroom:
Advertisements

Biological Agents.
OVERVIEW OF INDUSTRIAL HYGIENE UNIVERSITY OF HOUSTON – DOWNTOWN CAMPUS.
Biosafety in Microbiologic and Biomedical Laboratories The University of Texas at Tyler IACUC Education and Training *Note: Content not specific to UT.
Biosafety in the TB Laboratory
Biological Safety Training
Laboratory Orientation and Safety. Prevention of physical injuries and laboratory acquired infections with zoonotic disease agents Laboratory safety is.
Biological Laboratory Safety Additional Information.
Biological Laboratory Safety. REHS Rutgers Environmental Health and Safety REHS supports Rutgers University by providing comprehensive and professional.
Biosafety and Facility Design
BSL-2 Laboratory BIOHAZARD All Personal Protective Equipment shall be removed prior to leaving this work area. Eating, drinking, smoking applying cosmetics.
Health and Safety in the Laboratory
Laboratory Biosafety Pathogenic Microbiology and Virology Laboratories.
Biocontainment Practices Inside the Animal Lab
Biosafety in Microbiology laboratory
Lab Biosafety INTRODUCED BY ENAS A. RAOUF MOHAMMED CECR RESEARCH ASSISTANT SUPERVISED BY PROF. MOHAMED L. SALEM CECR DIRECTOR.
© 2012 O’Brien & Gere # obgPresentation Are there Microbes Lurking? June 12, 2012 | State University of NY Paul W. Tranchell CIH, CSP, RBP Project Manager.
Emergency Response to Biological Incidents Response to Biological Spills in the Laboratory (Intentional or Accidental)
CDC/NIH Vertebrate Animal Biosafety Level Criteria ► For all Animal Biosafety Levels (1 - 4)  IACUC Approval  Authorized access to facilities  Animal.
BIOLOGICAL HAZARDS RISK ASSESSMENT
Patient Safety Monitoring in International Laboratories (SMILE) 1 Biosafety in the Clinical Laboratory A SMILE Presentation.
Risk Assessment in Animal Biosafety ► Risk Assessment Factors  Pathogen/agent  Animal Model (species)  Procedures ► Proposed manipulations ► Assigned.
ERT 322 SAFETY AND LOSS PREVENTION BIOSAFETY AND BIOHAZARD SAFETY.
An Introduction to Biological Safety Dr. A. Mantalaris Biological Safety Officer (ACE 515, Tel: x45601)
Division of Environmental Health Department of Public Health and Social Services Guam Mosquito Laboratory.
ACADs (08-006) Covered Keywords Laboratory safety, eye protection, protective clothing, storing chemicals, labeling chemicals, eyewash, showers. Description.
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
East Carolina UniversityOffice of Prospective Health/Biological Safety Biological Safety Training.
Risk Group and Biosafety Level. Classification of Infective Agents by Risk Group Pathogenicity Pathogenicity Infectious Dose Infectious Dose Mode of Transmission.
Infection Prevention and Control Competencies for Healthcare Personnel Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
BIOSAFETY. BIORISK ASSESSMENT
Standard Microbiological Practices UT Biosafety Office
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
General Biosafety Tassanee Eamkamon Biosafety Professional Armed Forces Research Institute of Medical Sciences 23 March 2010.
RISK ASSESSMENT OF GMOs UNDER CONTAINED AND FIELD USE EXPERIMENTS Veronica O. Sinohin; Senior Science Research Specialist Ecosystems Research and Development.
Prevent Disease – Promote Wellness – Improve Quality of Life UNIVERSAL/STANDARD PRECAUTIONS BLOODBORNE PATHOGENS Michigan Department of Community Health.
Biosafety Recommendations for Laboratory Testing for TB
Chapter 4.  Mandatory for all persons working with laboratory animals  Safety training is also required  Vaccination may be required at some facilities:
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
Risk Assessment. Risk As defined by Kaplan and Garrick, risk analysis consists of answering three specific questions: what can happen? what is the chance.
CGMP Biopharmaceutical Facility Basic Construction.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
General Requirements for a BSL-3/4 Laboratory
Introduction to Biohazards: Risk Management
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Biosafety Levels Precautions so people researching or trying to identify organisms do not become infected While handling or testing clinical specimens,
Bloodborne Pathogens Training: Preventing Disease Transmission
Sterile Products Lab PHT 434
52 Table 1. Summary of Recommended Biosafety Levels for Infectious Agents. Biosafety Level Agents Practices Safety Equipment (Primary Barriers) Facilities.
Laboratory Animal Facilities. Introduction Those who use animals for experimental and diagnostic purposes have a moral obligation to take every care to.
 Occupational Health and Safety Administration (OSHA) is a federal agency that works to promote safety in all health care environments.  OSHA creates.
BIOSAFETY LEVEL 2 AWARENESS TRAINING UW Stout Laboratory Safety Biological Safety.
Biosafety- working Safely in a BSL-3 Laboratory
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
The IBC is: The Institutional Biosafety Committee (aka Biohazards Committee)
Working safely with Biological materials Aseptic technique, sterilization and tissue culture techniques.
Biosafety at Swinburne
SAFETY IN THE LABORATORY.
ROLE OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
CHAPTER 15 Biological Hazards.
Biosafety Overview for Laboratories
Biosafety Cabinet (BSC): What you need to know?
Laboratory Biosafety and Biosecurity
Working with Biological Hazards
Applying technical requirements of ISO/IEC 17025:2005 in the Zoonotic diseases testing laboratory. Discussion on the challenges M.A Motaung.
Compounding.
BSL-1 Laboratory BIOHAZARD
رعایت اصول ایمنی در آزمایشگاه
Biosafety Principles: Separation, Seclusion & Containment
Presentation transcript:

Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction with risk assessment to set Biosafety Levels.

Assignment of agent based on risk assessment Depends on agent and conditions of use Requires professional judgment World Health Organization National Institutes of Health

Suitable for work involving well-characterized agents not known to consistently cause disease in immunocompetent adult humans minimal potential hazard to laboratory personnel and the environment. laboratories are not necessarily separated from the general traffic patterns in the building. Work is typically conducted on open bench tops using standard microbiological practices. Special containment equipment or facility design is not required, Laboratory personnel must have specific training in the procedures conducted in the laboratory and must be supervised by a scientist with training in microbiology or a related science.

Biosafety Level 1

Builds upon BSL-1 BSL-2 is suitable for work involving agents that pose moderate hazards to personnel and the environment. Laboratory personnel have specific training in handling pathogenic agents Personnel are supervised by scientists competent in handling infectious agents and associated procedures Access to the laboratory is restricted when work is being conducted all procedures in which infectious aerosols or splashes may be created are conducted in biological safety cabinets (BSCs) or other physical containment equipment.

Biosafety Level 2

Is applicable to clinical, diagnostic, teaching, research, or production facilities where work is performed with indigenous or exotic agents that may cause serious or potentially lethal disease through inhalation route exposure. Laboratory personnel must receive specific training in handling pathogenic and potentially lethal agents Must be supervised by scientists competent in handling infectious agents and associated procedures. Biosafety Level 2 plus all procedures involving the manipulation of infectious materials must be conducted within BSCs, or other physical containment devices Personnel wear additional appropriate personal protective equipment including respiratory protection as determined by risk assessment A BSL-3 laboratory has special engineering and design features. o Directional air flow

Biosafety Level 3

Required for work with dangerous and exotic agents that pose a high individual risk of life-threatening disease, aerosol transmission, or related agent with unknown risk of transmission. Agents with a close or identical antigenic relationship to agents requiring BSL-4 containment must be handled at this level until sufficient data are obtained either to confirm continued work at this level, or re-designate the level. Laboratory staff must have specific and thorough training in handling extremely hazardous infectious agents. Laboratory staff must understand the primary and secondary containment functions of standard and special practices, containment equipment, and laboratory design characteristics. All laboratory staff and supervisors must be competent in handling agents and procedures requiring BSL-4 containment. Access to the laboratory is controlled by the laboratory supervisor in accordance with institutional policies Two types of laboratory providing absolute separation of the worker from the infectious agents o Suit Laboratory o Cabinet Laboratory

Biosafety Level 4

BSL-2 BSL-3 BSL-1 CDC/NIH Guidelines Biosafety Levels ( ) Lower Risk Higher Risk

Pathogenicity of the agent Modes of transmission and host range of organism Local availability of preventive measures Local availability of effective treatment World Health Organization National Institutes of Health

World Health Organization National Institutes of Health

World Health Organization National Institutes of Health

High individual risk, low community risk Pathogen usually causes serious human or animal disease but does not ordinarily spread to others Effective treatment and preventive measures are available World Health Organization National Institutes of Health

High individual and community risk A pathogen causes serious human or animal disease; readily transmitted from one individual to another Effective treatment and preventive measures are usually not available World Health Organization National Institutes of Health

Risk Group Biosafety LevelLaboratory TypeLaboratory Practices Safety Equipment 1 Basic – Biosafety Level 1 Basic teaching, research GMTNone; open bench work 2 Basic – Biosafety Level 2 Primary health services; diagnostic services, research GMT plus protective clothing, biohazards sign Open bench plus BSC for aerosols World Health Organization National Institutes of Health

Risk Group Biosafety LevelLaboratory TypeLaboratory Practices Safety Equipment 3 Containment- Biosafety Level 3 Special diagnostic services, research Level 2 + special clothing, access control, directed airflow BSC and/or other primary devices for all activities 4 Maximum Containment – Biosafety Level 4 Dangerous pathogen units Level 3 + airlock entry, shower exit, special waste disposal Class III BSC, or positive pressure suites with class II BSCs, double ended autoclave World Health Organization National Institutes of Health